Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Post by canadafanon May 12, 2020 9:19pm

326 Views

Post# 31020089

unexplainable..maybe Wed will come though again

With a bolt out the gate on Monday, over a million shares traded Canada & over 2 million on the Nas.
Tuesday? back to quiet-ville.
What changed?
What cause the surge on Monday ?
Stock runs are typically 3-4 days long.
Could it be with automated trading we complied 3 days into one , Monday?
None of the vast fundamentals mentioned on Monday went away Tuesday.
I find the whole thing quite strange.
Yes I am in for the long haul & will be holding to a decision.
Either a buy-out/partnership or broke.
Could take another year? Could be end of this year?
That long term is as mysterious as Monday/Tuesday trading.

Bullboard Posts

Investing in the 60/40 portfolio, is it still relevant?